Long-term prognosis of 69 patients with dermatomyositis or polymyositis

Clinical and Experimental Rheumatology

Volumn 14, Issue 3, 1996, Pages 263-274

  Maugars, Y M ^a   Berthelot, J M M ^a   Abbas, A A ^a   Mussini, J M B ^a   Nguyen, J M D ^a   Prost, A M ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

death; dermatopolymyositis; polymyositis; prognosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ANOREXIA; ARTICLE; ASTHENIA; CAUSE OF DEATH; CHILD; DERMATOMYOSITIS; DYSPHAGIA; DYSPHONIA; FEMALE; FIBROSING ALVEOLITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; MYALGIA; POLYMYOSITIS; PRIORITY JOURNAL; PROGNOSIS; SENESCENCE; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHILD; DERMATOMYOSITIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POLYMYOSITIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0029760847     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. BOHAN A, PETER JB: Polymyositis and dermatomyositis (1). N Engl J Med 1975; 292: 344-7.
2. BOHAN A, PETER JB: Polymyositis and dermatomyositis (2). N Engl J Med 1975; 292: 403-7.
3. MILLER FW, LEITMAN SF, GRONIN ME et al.: Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 1992; 326: 1380-4.
4. BARON M, SMALL P: Polymyositis/dermatomyositis: clinical features and outcomes in 22 patients. J Rheumatol 1985; 12: 283-6.
5. BASSET-SEGUIN N, ROUJEAU JC, GHERARDI R, GUILLAUME JC, REVUZ J, TOURAINE R: Prognostic factors and predictive signs of malignancy in adult dermatomyositis. Arch Dermatol 1990; 126: 633-7.
6. BENBASSAT J, GEFFEL D, LARHOLT K, SUKENIK S, MORGENSTERN U, ZLOTNICKA: Prognostic factors in polymyositis/dermatomyositis: a computer-assisted analysis of 92 cases. Arthritis Rheum 1985; 28: 249-55.
7. BOHAN A, PETER JB, BOURNAN RL, PEARSON CM: A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977; 56: 255-86.
8. CHWALINSKA-SADOWSKA H, MALDYKOWA H: Polymyositis-dermatomyositis: 25 years of follow-up of 50 patients' disease course, treatment and prognostic factors. Mater Med Pol 1990; 22: 213-8.
9. DE VERE R, BRADLEY WG: Polymyositis: its presentation, morbidity and mortality. Brain 1975; 98: 637-66.
10. GODEAU P, HERSON S, HERREMAN G et al.: Evolution et pronostic à long terme de 50 cas de dermatomyosites et polymyosites. Rev Med Interne 1980; 1: 29-36.
11. HENRICKSSON KG, SANDESTEDT P: Polymyositis - treatment and prognosis. A study of 107 patients. Acta Neurol Scand 1982; 65: 280-300.
12. HIDANO A, KANEKO K, ARAI Y, KIKUCHI R: Survey of the prognosis for dermatomyositis with special reference to its association with malignancy and pulmonary fibrosis. J Dermatol 1986; 13: 233-41.
13. HOCHBERG MC, FELDMAN D, STEVENS MB: Adult onset polymyositis-dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients, with a review of the literature. Semin Arthritis Rheum 1986; 3: 168-78.
14. HOFFMAN GS, FRANCK W, RADDATZ DA, STALLONS L: Presentation, treatment and prognosis of idiopathic inflammatory muscle disease in a rural hospital. Am J Med 1983; 75: 43 3-8.
15. LOGAN RG, BANDERA JM, MICKKELSEN WM, DUFF JF: Polymyositis: a clinical study. Ann Intern Med 1966; 5: 996-1007.
16. LOVE LA, LEFF RL, FRASER DD, TARGOFF IN, DALAKAS M, PLOTZ PH, MILLER FW: A new approach to the classification of idiopathic inflammatory myopathy: myositis specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991; 70: 360-74.
17. MEDSGER TA, ROBINSON H, MASI AT: Factors affecting survivorship in polymyositis. A life table study of 124 patients. Arthritis Rheum 1971; 14: 249-58.
18. MURABAYASHI K, SAITO E, OKADA S, OGAWA T, KIROSHITA M: Prognosis of life in polymyositis/dermatomyositis. Ryumachi 1991; 31: 391-7.
19. O'LEARY PA, WAISMAN M: Dermatomyositis: a study of 40 cases. Arch Dermatol Syph 1940; 41: 1001-19.
20. ODDIS CV, MEDSGER TA, HILL P: Follow-up of a national cohort of 322 polymyositis-dermatomyositis patients. Arthritis Rheum 1991; 34: abstract S149.
21. RAMIREZ G, ASHERSON RA, KHAMASHTA MA, CERVERA R, D'CRUZ D, HUGHES CRV: Adult onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment. Semin Arthritis Rheum 1990; 20: 114-
22. ROSE AL, WALTON JN: Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis. Brain 1966; 89: 747-68.
23. RIDDOH D, MORGAN-HUGHES JA: Prognosis in adult polymyositis. J Neurol Sci 1975; 26: 71-80.
24. SERRATRICE G, SCHIANO A, PELLISSIER JF, POUGET J: Etude de 133 cas de polymyosites. Rev Neurol 1986; 12: 906-17.
25. WINKELMANN RK, MULDER DW, LAMBERT EH, HOWARD FM, DESSNER GR: Course of dermatomyositis-polymyositis: comparison of untreated and cortisone-treated patients. Mayo Clin Proc 1968; 43: 545-56.
26. YOSHIOKA M, OKUNO T, MIKAWA H: Prognosis and treatment of polymyositis with particular reference to steroid-resistant patients. Arch Dis Child 1985; 60: 236-44.
27. MEDSGER TA JR, ODDIS CV: Polymyositis and dermatomyositis. In: BELCH JJF, ZURIER RB (Eds.): Connective Tissue Disease, London, 1995, p 91-6.
28. DIXON WJ (Ed): Statistical Software Manual, University of California, Berkeley, 1990.
29. TANIMOTO K, KEIICHIRO N, SHOGO K, MORI S, HIROAKI U, NISHITANI H, TAKESHI S, KIUCHI T, OHASHI Y: Classification criteria for polymyositis and dermatomyositis. J Rheumatol 1995; 22: 668-74.
30. SIGURGEIRSSON B, LINDELÖF B, EDHAG D, ALLANDER E: Risk of cancer in patients with dermatomyositis or polymyositis. N Engl J Med 1992; 326: 363-7.
31. TYMMS K, WEBB J: Dermatopolymyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol 1985; 12: 1140-8.
32. BARNES BE, MAWR B: Dermatomyositis and malignancy. A review of the literature. Ann Intern Med 1976; 84: 68-76.
33. FRAZIER AR, MILLER RD: Interstitial pneumonitis in association with polymyositis and dermatomyositis. Chest 1974; 65: 403-7.
34. SALMERON G, GREENBERG SD, LIDSKY MD: Polymyositis and diffuse interstitial lung disease. Arch Intern Med 1981; 141: 1005-10.
35. SONGCHAROEN S, RAJU SF, PENNEBAKER JB: Interstitial lung disease in polymyositis and dermatomyositis. J Rheumatol 1980; 7: 353-60.
36. TAKIZAWA H, SHIGA J, MOROI Y, MIYACHI S, NISHIWAKI M, MIYAMOTO T: Interstitial lung disease in dermatomyositis: clinicopathological study. J Rheumatol 1987; 14: 102-7.
37. 1, in connective tissue diseases. A marker of a subset in polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983; 26: 604-11.
38. ARSURA EL, GREENBERG AS: Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin Arthritis Rheum 1988; 18: 29-37.
39. ASKARI AD: Cardiac abnormalities in inflammatory myopathy. Clin Rheum Dis 1984; 10: 131-49.
40. ASKARI AP, HUETTNER TL: Cardiac abnormalities in polymyositis/dermatomyositis. Semin Arthritis Rheum 1982; 127: 208-19.
41. BROTTIER L, COSTE P, COMBE C, BRUCHÈRE C, BONNET J, BRIAND H: Complications cardiaques des dermatopolymyosites. Arch Mal Coeur 1987; 7: 1133-8.
42. DENBOW CE, LIE JT, TANCREDI RG, BUNCH TW: Cardiac involvement in polymyositis. A clinicopathologic study of 20 autopsied patients. Arthritis Rheum 1979; 22: 1088-92.
43. GOTTDIENER JS, SHERBER HS, HAWLEY RJ, ENGEL WK: Cardiac manifestations in polymyositis. Am J Cardiol 1978; 41: 1141-9.
44. HAUPT HM, HUTCHINS GM: The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. Am J Cardiol 1982; 50: 998-1006.
45. LOIRE R: Les myocardiopathies de la dermatomyosite et de la périartérite noueuse. Arch Med Coeur 1977; 71: 413-6.
46. JAIN R, CHARTASH E, SUSIN M, FURIE R: Systemic lupus erythematosus complicated by thrombotic microangiopathy. Semin Arthritis Rheum 1994; 24: 173-82.
47. DICKEY BF, MYERS AR: Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum 1984; 4: 60-76.
48. LACKHANPAL S, LIE JT, CONN DL, MARTIN II WJ: Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological study analysis of 65 autopsy cases. Ann Rheum Dis 1987; 46: 23-9.
49. MCKENDRY R JR: Influence of age at onset on the duration of treatment of idiopathic adult polymyositis and dermatomyositis. Arch Intern Med 1987; 147: 1989-91.
50. HOCHBERG MC, LOPEZ-ACUNA D, GITTELOHN AM: Mortality from polymyositis and dermatomyositis in the United States, 1968-1978. Arthritis Rheum 1983; 12: 1465-71.
51. TAIEB A, GUICHARD C, SALAMON R, MALVILLE J: Prognosis in juvenile dermatopolymyositis: a cooperative retrospective study of 70 cases. Pediatr Dermatol 1985; 2: 275-81.
52. TAZELAAR HD, VIGGIANO RW, PICKERSGILL J, COLBY TV: Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Ann Rev Respir Dis 1990; 141: 727-33.
53. SCHWARZ MI, MATHAY RA, SAHN SA, STANFORD RE, MARMORSTEIN BL, SCHEINHORN DJ: Interstitial lung disease in polymyositis and dermatomyositis: analysis of 6 cases and review of the literature. Medicine 1976; 55: 89-104.
54. CARPENTER JR, BUNCH TW, ENGEL AG, O'BRIEN PC: Survival in polymyositis: corticosteroid and risk factors. J Rheumatol 1977; 4: 207-14.
55. FAFALAK RG, PETERSON MGE, KAGEN LJ: Strength in polymyositis and dermatomyositis: best outcome in patients treated early. J Rheumatol 1994; 21: 643-8.
56. JOFFE MM, LOVE LA, LEFF RL et al.: Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and comparison of their efficacy. Am J Med 1993; 94: 379-87.
57. BOWYER SL, BLANE CE, SULLIVAN DP, CASSIDY JT: Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. J Pediatr 1983; 103: 882-8.
58. MILLER LC, MICKAEL AF, KIM Y: Childhood dermatomyositis. Clinical course and long-term follow-up. Clinical Pediatrics 1987; 26: 561-6.
59. PACHMAN LM, COOKE N: Juvenile dermatomyositis: a clinical and immunologic study. J Pediatr 1980; 96: 226-34.